ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)
Japan flag Japan · Delayed Price · Currency is JPY
2,160.00
-30.00 (-1.37%)
Nov 13, 2026, 3:30 PM JST

TYO:4886 Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
6,7786,9916,1929,8625,3576,163
Depreciation & Amortization
3,1443,0852,2472,6623,1272,885
Loss (Gain) From Sale of Assets
76-9030026-3,466
Loss (Gain) From Sale of Investments
-1,230-1,230-127-3,340-1241,151
Loss (Gain) on Equity Investments
368293534119-18
Other Operating Activities
-1,240757-3,938-1,532-854-2,224
Change in Accounts Receivable
-1,588-8671,203-370-742-1,361
Change in Inventory
-933-2,684-2,675-2,713-2,627-687
Change in Accounts Payable
-500-1,5393391,494-980412
Change in Other Net Operating Assets
8581,587-1,109-4,620169-13
Operating Cash Flow
5,7336,3032,4851,4863,3512,842
Operating Cash Flow Growth
135.83%153.64%67.23%-55.66%17.91%-56.55%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-969-2,549-2,960-1,320-461-579
Sale of Property, Plant & Equipment
-166-1-10,312
Cash Acquisitions
-3,908-3,908-2,189-1,464--53
Divestitures
4747----
Sale (Purchase) of Intangibles
-88-325-602-133-285-1,798
Investment in Securities
4,6671,7167523,778-210-45
Other Investing Activities
-794-899-1,125844-170-1,094
Investing Cash Flow
-1,045-5,752-6,1241,706-1,1266,743

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-3,5003,000---
Total Debt Issued
-3,5003,000---
Short-Term Debt Repaid
--738----50
Long-Term Debt Repaid
--1,937-4,680-3,138-1,423-2,298
Total Debt Repaid
-3,015-2,675-4,680-3,138-1,423-2,348
Net Debt Issued (Repaid)
-3,015825-1,680-3,138-1,423-2,348
Repurchase of Common Stock
---955-248
Common Dividends Paid
-1,704-1,617-1,275-792-452-398
Other Financing Activities
-36-26-1-22--2
Financing Cash Flow
-4,755-818-2,956-3,943-1,820-2,996

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-135-208-97-15-2-
Miscellaneous Cash Flow Adjustments
--1556--1-
Net Cash Flow
-202-476-6,136-7664026,589

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
4,7643,754-4751662,8902,263
Free Cash Flow Growth
----94.26%27.71%-58.38%
Free Cash Flow Margin
6.66%5.28%-0.74%0.26%4.78%4.00%
Free Cash Flow Per Share
167.45132.26-16.765.86102.3479.77
Levered Free Cash Flow
1,484806.5-6,5686,9722,067633.5
Unlevered Free Cash Flow
1,613945.25-6,5366,9972,098668.5

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
20522251415158
Cash Income Tax Paid
1,585-7574,0261,6118501,385
Change in Working Capital
-2,163-3,503-2,242-6,209-4,180-1,649